UniSa - IRIS Institutional Research Information System

TRIGGIANI, Massimo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 11.765
NA - Nord America 10.905
EU - Europa 2.687
SA - Sud America 1.110
AF - Africa 135
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 5
Totale 26.624
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.762
HK - Hong Kong 6.840
SG - Singapore 2.161
CN - Cina 1.000
BR - Brasile 831
VN - Vietnam 816
IT - Italia 541
UA - Ucraina 510
RU - Federazione Russa 356
DE - Germania 334
TR - Turchia 255
FR - Francia 219
IE - Irlanda 213
KR - Corea 194
AR - Argentina 132
FI - Finlandia 125
IN - India 97
GB - Regno Unito 94
SE - Svezia 87
IQ - Iraq 66
BD - Bangladesh 65
CA - Canada 60
ES - Italia 41
MX - Messico 41
EC - Ecuador 38
ID - Indonesia 38
CO - Colombia 37
ZA - Sudafrica 36
AT - Austria 34
JP - Giappone 33
PK - Pakistan 33
PL - Polonia 26
SA - Arabia Saudita 22
NL - Olanda 21
MA - Marocco 20
PY - Paraguay 18
VE - Venezuela 18
AE - Emirati Arabi Uniti 17
UZ - Uzbekistan 16
JO - Giordania 14
MY - Malesia 14
KE - Kenya 13
CL - Cile 12
CZ - Repubblica Ceca 12
PE - Perù 12
EG - Egitto 10
NZ - Nuova Zelanda 10
PH - Filippine 10
CR - Costa Rica 9
IL - Israele 9
ET - Etiopia 8
JM - Giamaica 8
KZ - Kazakistan 8
LT - Lituania 8
AL - Albania 7
AU - Australia 7
CH - Svizzera 7
DZ - Algeria 7
NP - Nepal 7
PA - Panama 7
SY - Repubblica araba siriana 7
TN - Tunisia 7
UY - Uruguay 7
AZ - Azerbaigian 6
PS - Palestinian Territory 6
BG - Bulgaria 5
BY - Bielorussia 5
HN - Honduras 5
MD - Moldavia 5
PT - Portogallo 5
RS - Serbia 5
AM - Armenia 4
BO - Bolivia 4
CI - Costa d'Avorio 4
EU - Europa 4
GR - Grecia 4
SN - Senegal 4
BA - Bosnia-Erzegovina 3
BE - Belgio 3
GN - Guinea 3
HU - Ungheria 3
LB - Libano 3
MK - Macedonia 3
NG - Nigeria 3
NI - Nicaragua 3
OM - Oman 3
SI - Slovenia 3
TH - Thailandia 3
BF - Burkina Faso 2
BN - Brunei Darussalam 2
BZ - Belize 2
CG - Congo 2
CY - Cipro 2
DO - Repubblica Dominicana 2
GE - Georgia 2
GP - Guadalupe 2
KG - Kirghizistan 2
KH - Cambogia 2
KW - Kuwait 2
LY - Libia 2
Totale 26.590
Salva come PNG Salva come JPEG
Città #
Hong Kong 6.832
Ann Arbor 2.093
Woodbridge 1.132
Singapore 1.039
San Jose 777
Chandler 699
Jacksonville 662
Princeton 627
Ashburn 569
Houston 544
Dallas 532
Wilmington 392
Dong Ket 326
The Dalles 283
Council Bluffs 261
Izmir 223
Dublin 209
Lauterbourg 197
Ho Chi Minh City 174
Beijing 171
Andover 147
Nanjing 133
Boardman 116
Moscow 106
Pellezzano 103
Hanoi 99
Los Angeles 87
Munich 79
New York 74
Naples 66
São Paulo 64
Nuremberg 61
Washington 57
Salerno 55
Düsseldorf 50
Shenyang 49
Fairfield 46
Santa Clara 46
Changsha 45
Columbus 43
Hebei 42
Buenos Aires 41
Norwalk 39
Jiaxing 38
Nanchang 37
Redwood City 37
Haiphong 28
Tokyo 28
Baghdad 27
Dearborn 27
Rio de Janeiro 27
Montreal 25
Orem 25
Tianjin 25
Da Nang 24
Rome 23
Chicago 22
Frankfurt am Main 22
Lappeenranta 22
Turku 22
Warsaw 22
Brooklyn 21
Boston 20
Milan 20
Seattle 20
Poplar 19
London 18
Mestre 18
Johannesburg 17
Quito 17
Belo Horizonte 16
Denver 16
Pune 16
Vienna 15
Curitiba 14
Phoenix 14
Seoul 14
Stockholm 14
Amman 13
Asunción 13
Chennai 13
Dhaka 13
Atlanta 12
Mexico City 12
Shanghai 12
Brasília 11
Cambridge 11
Nairobi 11
Tashkent 11
Biên Hòa 10
Charlotte 10
Hải Dương 10
Istanbul 10
Latina 10
Manchester 10
New Delhi 10
Raleigh 10
Amsterdam 9
Casablanca 9
Falls Church 9
Totale 20.399
Salva come PNG Salva come JPEG
Nome #
Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - EIP on AHA Twinning Reference Site (GARD research demonstration project) 954
La triptasi sierica nella diagnosi di mastocitosi sistemica in pazienti adulti senza lesioni cutanee 651
Long-Term Clinical and Sustained REMIssion in Severe Eosinophilic Asthma Treated With Mepolizumab: The REMI-M Study 570
Validation of the MASK-rhinitis visual analogue scale on smartphone screens to assess allergic rhinitis control 565
Personalized Management Strategies in Mast Cell Disorders: ECNM-AIM User's Guide for Daily Clinical Practice 516
Fragments of truth: T-cell targets of polyclonal immunoglobulins in autoimmune diseases 499
Triggers and prodromal symptoms of angioedema attacks in patients with hereditary angioedema 387
Control of arachidonate levels within inflammatory cells. 374
A nationwide survey of hereditary angioedema due to C1 inhibitor deficiency in Italy 360
Diagnostic issues faced by a rare disease healthcare network during Covid-19 outbreak: Data from the Campania Rare Disease Registry 355
Anaphylaxis and cardiovascular diseases 323
Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma 314
Integrated care pathways for airway diseases (AIRWAYS-ICPs) 277
The Normal Range of Baseline Tryptase Should Be 1 to 15 ng/mL and Covers Healthy Individuals With HαT 273
KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on Mastocytosis 272
Immunoglobulin G (IgG) anticardiolipin antibodies and recurrent cardiovascular events. A systematic review and Bayesian meta-regression analysis 230
Multidisciplinary challenges inmastocytosis and how to address with personalizedmedicine approaches 224
Adverse reactions to drugs and biologics in patients with clonal mast cell disorders: A Work Group Report of the Mast Cells Disorder Committee, American Academy of Allergy, Asthma & Immunology 212
Diagnostic and therapeutic management of hereditary angioedema due to C1-inhibitor deficiency: The Italian experience 210
Characterization of platelet-activating factor synthesized by normal and granulocyte-macrophage colony-stimulating factor-primed human eosinophils. 207
A review of hereditary angioedema and recombinant human C1-inhibitor treatment 205
A randomised, placebo-controlled, double blind phase III study of the efficacy and safety of recombinant human C1 inhibitor for the treatment of acute attacks in patients with hereditary angioedema 201
Heterogeneity of human Fc epsilon RI-bearing cells. 198
Antigen-induced generation of lyso-phospholipids in human airways. 179
Allergia alimentare e probiotici: nuovi aspetti sulle interazioni tra il sistema immunitario ed i batteri commensali intestinali 179
Secretory phospholipases A2 activate selective functions in human eosinophils 174
Stress and Psychological Factors in the Variable Clinical Phenotype of Hereditary Angioedema in Children: A Pilot Study 169
Arachidonic acid metabolism during antigen and ionophore activation of the mouse bone marrow derived mast cell. 165
Activation of human basophils by staphylococcal protein A. I. The role of cyclic AMP, arachidonic acid metabolites, microtubules and microfilaments. 163
Activation of human inflammatory cells by secreted phospholipases A2 157
Current concepts on diagnosis and treatment of mastocytosis. 155
Activation of cytokine production by secreted phospholipase A2 in human lung macrophages expressing the M-type receptor 153
Advances in the classification and treatment of mastocytosis: Current status and outlook toward the future 153
Molecular and cellular biology of mast cells and basophils. 149
Antileucotrieni nell'asma bronchiale: bilancio e prospettive 148
ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle 148
AIRWAYS-ICPs (European Innovation Partnership on Active and Healthy Ageing) from concept to implementation 142
A unique case of angioedema with anti-C1 inhibitor antibodies and normal C1 inhibitor levels 141
Enhanced Expression of CD47 Is Associated With Off-Target Resistance to Tyrosine Kinase Inhibitor Gefitinib in NSCLC 137
Biomarkers of the involvement of mast cells, basophils and eosinophils in asthma and allergic diseases 136
Non lymphomatous clonal B-Cell populations in enlarged lymph nodes in acquired immunodeficiency syndrome. 136
MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis 133
Editorial overview: Immunomodulation: Modulation of the immune system: Per aspera ad astra 131
L'acido ialuronico nella regolazione delle risposte infiammatorie ed immunologiche 129
Biochemical functions of a pool of arachidonic acid associated with triglycerides in human inflammatory cells. 128
Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group 128
Assay of antibody to group A streptococcal carbohydrate by enzyme-linked immunosorbent assay. 127
Human Macrophages and Monocytes Express Functional Na+/Ca2+ Exchangers 1 and 3Sodium Calcium Exchange: A Growing Spectrum of Pathophysiological Implications 126
A Survey of Clinical Features of Allergic Rhinitis in Adults 125
Efficacy and safety of recombinant human C1-inhibitor for the treatment of attacks of hereditary angioedema: European open-label extension study 123
Biological effects of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine in the human neutrophil. 123
Home Therapy with Plasma-Derived C1 Inhibitor: A Strategy to Improve Clinical Outcomes and Costs in Hereditary Angioedema 122
Pharmacological modulation of human mast cells and basophils 122
Benzene metabolites inhibit the release of proinflammatory mediators and cytokines from human basophils 121
Elevated plasma levels of vascular permeability factors in C1 inhibitor-deficient hereditary angioedema 121
Are mast cells MASTers in HIV-1 infection? 119
Biomarkers for evaluation of mast cell and basophil activation 119
Risk and management of patients with mastocytosis and MCAS in the SARS-CoV-2 (COVID-19) pandemic: Expert opinions 118
Molecular diagnosis and the Italian Board for ISAC. 117
360 degree perspective on allergic rhinitis management in Italy: A survey of GPs, pharmacists and patients 115
Evaluation of vaccination safety in children with mastocytosis 115
Relative amounts of 1-O-alkyl- and 1-acyl-2-acetyl-sn-glycero-3-phosphocholine in stimulated endothelial cells. 114
Research needs in allergy: an EAACI position paper, in collaboration with EFA 114
Refined diagnostic criteria and classification of mast cell leukemia (MCL) and myelomastocytic leukemia (MML): a consensus proposal 114
Secretory phospholipases A2 in inflammatory and allergic diseases: not just enzymes. 113
What we should learn from the London Olympics 113
Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis – A EUFOREA-ARIA-EPOS-AIRWAYS ICP statement 113
Mast cells as effector cells of innate immunity and regulators of adaptive immunity 112
Short-term and long-term role of platelet activating factor as a mediator of in vivo platelet aggregation. 111
Inhibition of IgE-mediated release of histamine and peptide leukotriene from human basophils and mast cells by forskolin. 111
Arachidonic acid remodeling in human inflammatory cells migrating to the lung in vivo. 111
Perioperative anaphylactic risk score for risk-oriented premedication. 109
Migration of human inflammatory cells into the lung results in the remodeling of arachidonic acid into a triglyceride pool. 108
European Competence Network on Mastocytosis (ECNM): 10-year jubilee, update, and future perspectives 108
Expression and function of angiopoietins and their tie receptors in human basophils and mast cells 108
Evidence that increasing the cellular content of eicosapentaenoic acid does not reduce the biosynthesis of platelet-activating factor. 107
Factors that influence the proportions of platelet-activating factor and 1-acyl-2-acetyl-sn-glycero-3-phosphocholine synthesized by the mast cell. 107
Oxidative stress markers are increased in patients with mastocytosis 106
Role of human mast cells and basophils in bronchial asthma. 106
Sensitization to Common and Uncommon Pets or Other Furry Animals: Which May Be Common Mechanisms? 106
HIV-1 envelope gp41 peptides promote migration of human FcεRI+ cells and inhibit IL-13 synthesis through interaction with formyl peptide receptors 106
Inhibition of histamine and prostaglandin D2 release from human lung mast cells by ciclosporin A. 105
Management of chronic spontaneous urticaria: practical parameters 105
Role of human FcεRI+ cells in HIV-1 infection 105
Differential roles for triglyceride and phospholipid pools of arachidonic acid in human lung macrophages. 104
ARIA Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology 104
Phenotypical and functional heterogeneity of human lung macrophages 103
Mutational Spectrum of the C1 Inhibitor Gene in a Cohort of Italian Patients with Hereditary Angioedema: Description of Nine Novel Mutations 103
Proposed diagnostic algorithm for patients with suspected mastocytosis: a proposal of the European Competence Network on Mastocytosis 103
Cyclosporin A rapidly inhibits mediator release from human basophils presumably by interacting with cyclophilin. 102
Bone Marrow Failure Syndromes, Overlapping Diseases with a Common Cytokine Signature 102
Influence of immunologic activation and cellular fatty acid levels on the catabolism of platelet-activating factor within the murine mast cell (PT-18). 101
Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; The American Academy of Allergy, Asthma & Immunology; And the European Academy of Allergology and Clinical Immunology 101
Clinical presentation and management practice of systemic mastocytosis. A survey on 460 Italian patients 101
Mastocytosis presenting as cardiac emergency 101
Simplexide Induces CD1d-Dependent Cytokine and Chemokine Production from Human Monocytes 100
Recent advances in our understanding of the biochemical interactions between platelet-activating factor and arachidonic acid. 100
Component resolved diagnosis (CRD): how much is it presently used by Italian allergists? 100
Treatment of chronic spontaneous urticaria with an inadequate response to H1-antihistamines: An expert opinion 100
Icatibant treatment for acquired C1-inhibitor deficiency: a real-world observational study. 99
Totale 17.759
Salva come PNG Salva come JPEG
Categoria #
all - tutte 83.453
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 83.453
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021463 0 0 0 0 0 0 0 0 0 11 99 353
2021/20221.047 9 3 4 18 10 19 9 44 166 139 137 489
2022/20231.740 184 104 59 200 244 388 12 165 260 6 93 25
2023/20241.002 82 110 122 49 97 174 23 44 11 40 47 203
2024/20252.428 79 34 33 96 109 283 353 246 465 199 281 250
2025/202613.533 1.342 3.676 3.071 568 1.025 558 1.660 361 410 862 0 0
Totale 26.931